3002.51.00.00/Treg Cell Therapy for Autoimmune Diseases/China

Treg Cell Therapy for Autoimmune Diseases from China

Regulatory T-cells (Tregs) expanded ex vivo from patient blood, modified for enhanced suppressive function, used in treating graft-versus-host disease post-transplant. HTS 3002.51.00.00 covers these as cell therapy products—biotechnologically modified cell cultures for immunotherapy. They restore immune tolerance by suppressing overactive responses.

Duty Rate — China → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Include lot-specific potency assays and sterility test results in import documentation

• Ship under IATA dangerous goods regulations for Category A infectious substances